Could your own cells fight parkinson? new brain implant trial begins

NCT ID NCT06344026

ENROLLING_BY_INVITATION Disease control Sponsor: Aspen Neuroscience Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests whether implanting a person's own lab-grown dopamine cells into their brain is safe for Parkinson disease. Nine participants aged 40-75 with Parkinson for at least 4 years will receive the injection. The goal is to see if the cells can replace lost dopamine-producing neurons and improve motor symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE

Contacts and locations

Show contact details

Locations

Emory University

Atlanta, Georgia, 30322, United States
Feinstein Institutes

Manhasset, New York, 11030, United States
Scripps Health

La Jolla, California, 92037, United States
University of Arizona - Banner Health

Tucson, Arizona, 85724, United States
University of California, Irvine

Orange, California, 92868, United States
University of California, Los Angeles

Los Angeles, California, 90095, United States
University of California, San Diego

San Diego, California, 92037, United States
University of California, San Francisco

San Francisco, California, 94143, United States
University of Colorado

Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.